Inflammation has been recognized as a major pathophysiological contributor to the entire
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …

It has long been observed that heart failure (HF) is associated with measures of systemic
inflammation. In recent years, there have been significant advancements in our …

Despite mounting evidence demonstrating the significance of inflammation in the
pathophysiological mechanisms of heart failure (HF), most large clinical trials that target the …

The increasing prevalence of heart failure poses enormous challenges for health care
systems worldwide. Despite effective medical interventions that target neurohumoral …

Inflammation plays a central role in the development of heart failure, especially in heart
failure with preserved ejection fraction (HFpEF). Furthermore, the inflammatory response …

Chronic heart failure (CHF) represents a major public health burden, and its prognosis is
comparable to that of different malignant diseases. Our understanding of CHF has …

Chronic inflammation underlies a variety of seemingly unrelated conditions including
coronary artery disease. The interest in exploring the role of inflammation in heart failure …

As a greater proportion of patients survive their initial cardiac insult, medical systems
worldwide are being faced with an ever-growing need to understand the mechanisms …

Despite significant advances in the prevention and treatment of heart failure (HF), the
prognosis in patients who have been hospitalised on at least one occasion due to …

Patients with chronic heart failure (HF) are characterized by systemic inflammation, as
evident by raised circulating levels of several inflammatory cytokines with increasing levels …